Position in GMAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,121,568
+$641,589 QoQ
Shares Held
259,249
+7.3% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. GMAB ranks #126 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in GMAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,121,568 | 259,249 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,479,979 | 241,520 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $10,469,441 | 339,917 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,062,516 | 328,090 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $11,730,642 | 567,795 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,374,077 | 683,048 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,910,285 | 474,858 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $25,707,390 | 1,054,446 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $27,574,418 | 1,097,271 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,378,978 | 1,082,547 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $28,310,978 | 889,164 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,176,359 | 912,287 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $34,079,611 | 896,596 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,573,954 | 995,073 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $38,295,031 | 903,611 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $25,172,277 | 783,451 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,368,069 | 811,575 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $30,757,339 | 850,120 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,070,692 | 861,241 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $49,278,827 | 1,127,662 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $44,452,679 | 1,088,726 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $28,429,135 | 865,950 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $39,011,803 | 959,464 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $30,787,250 | 840,952 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,835,656 | 673,817 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $23,656,936 | 1,116,420 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||